e-learning
resources
Virtual 2020
Monday, 07.09.2020
Right ventricular function and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long-term hemodynamic benefits after ‘treat-to-close’ for intracardiac shunts and pulmonary hypertension
R. Vanderpool (Tucson, United States of America), S. Klewer (Tucson, United States of America), F. Rischard (Tucson, United States of America), M. Seckeler (Tucson, United States of America)
Source:
Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Session:
Right ventricular function and pulmonary hypertension
Session type:
Oral Presentation
Number:
4048
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Vanderpool (Tucson, United States of America), S. Klewer (Tucson, United States of America), F. Rischard (Tucson, United States of America), M. Seckeler (Tucson, United States of America). Long-term hemodynamic benefits after ‘treat-to-close’ for intracardiac shunts and pulmonary hypertension. 4048
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
The definition of pulmonary hypertension: history, practical implications and current controversies
ERS statement on chronic thromboembolic pulmonary hypertension
Related content which might interest you:
Non-invasive monitoring of intrapulmonary shunt in patients with pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Spontaneous hemodynamic variability in pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 464s
Year: 2003
Non-invasive hemodynamic assessment in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Right-to-left shunt in pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007
Successful multimodality managements of severe pulmonary artery hypertension in pregnancy with VA-ECMO and atrial septostomy using stent
Source: International Congress 2019 – CCC Respiratory critical care
Year: 2019
Acute hemodynamic effects of riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011
Intracardiac shunt measurement by MRI in patients with pulmonary arterial hypertension caused by a congenital septum defect
Source: Eur Respir J 2005; 26: Suppl. 49, 560s
Year: 2005
Preoperative pulmonary risk assessment of pulmonary arterial hypertension in patients undergoing cardiac surgery
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
The use of perioperative intravenous sildenafil in patients with mitral valve disease and co-existent pulmonary hypertension during cardiac surgery
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
Source: Eur Respir J, 49 (5) 1601980; 10.1183/13993003.01980-2016
Year: 2017
Apelin improves cardiac output in patients with pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy
Source: Eur Respir J 2001; 17: 653-659
Year: 2001
Impact on survival of pulmonary function abnormalities in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Scleroderma-related pulmonary hypertension and cardiac tamponade
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007
The long-term prognostic value of extracted thrombus and hemodynamics and in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers
Year: 2012
Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Early improvements predict outcomes in pulmonary arterial hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept